Regenxbio Inc (RGNX)
Debt-to-capital ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Total stockholders’ equity | US$ in thousands | 311,742 | 363,100 | 405,855 | 465,139 | 516,195 | 563,824 | 630,519 | 689,669 | 764,298 | 461,414 | 507,245 | 554,504 | 377,753 | 415,660 | 397,861 | 420,152 | 450,197 | 468,395 | 494,592 | 487,053 |
Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $311,742K)
= 0.00
The debt-to-capital ratio of Regenxbio Inc has remained consistently at 0.00 across all quarters of the past two years. This indicates that the company has not utilized any debt to finance its operations or growth initiatives during this period. A debt-to-capital ratio of 0.00 typically suggests that the company relies solely on equity financing, which can be advantageous as it reduces the financial risk associated with debt obligations. However, it's also worth noting that excessive reliance on equity financing may limit the company's ability to take advantage of leverage and potentially higher returns on investment.
Peer comparison
Dec 31, 2023